Navigation Links
Par Pharmaceutical Companies, Inc. Shareholder Alert: Bernstein Liebhard LLP Announces Investigation Of Acquisition By TPG
Date:7/16/2012

NEW YORK, July 16, 2012 /PRNewswire/ -- Bernstein Liebhard LLP is investigating whether the Board of Directors of Par Pharmaceutical Companies, Inc. ("Par" or the "Company") (NYSE: PRX) breached its fiduciary duty to its shareholders in agreeing to sell Par to an affiliate of TPG.

(Logo:  http://photos.prnewswire.com/prnh/20120202/MM47134LOGO )

Under the terms of the agreement, Par shareholders will receive $50.00 in cash for each share they own.  The investigation is focused on the potential unfairness of the price to Par shareholders and the process by which the Par Board of Directors considered and approved the transaction.

If you are interested in discussing your rights as a Par stockholder, with no obligation or cost to you, please contact U. Seth Ottensoser at:

(877) 779-1414
or
Ottensoser@bernlieb.com.

Bernstein Liebhard LLP has pursued hundreds of securities, consumer and shareholder rights cases and recovered over $3 billion for its clients.  It has been named to The National Law Journal's "Plaintiffs' Hot List" in each of the last nine years.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
(877) 779-1414
www.bernlieb.com

ATTORNEY ADVERTISING. © 2012 Bernstein Liebhard LLP.  The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414.  The lawyer responsible for this advertisement in the State of Connecticut is Michael S. Bigin.  Prior results do not guarantee or predict a similar outcome
'/>"/>

SOURCE Bernstein Liebhard LLP
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Report Presents a Framework for Successful New Oncology Product Launches in the Pharmaceutical Sector
2. Savient Pharmaceuticals to Hold First Quarter 2012 Financial Results Conference Call on Wednesday, May 9, 2012
3. Pharmaceutical Industry Service Company Awarded The UKs Most Prestigious Business Accolade in Recognition of Outstanding Achievement in International Trade
4. Auxilium Pharmaceuticals to Present at the Deutsche Bank 37th Annual Healthcare Conference
5. Simcere Pharmaceutical Group to Announce First Quarter 2012 Financial Results on Wednesday, May 9, 2012
6. Nouveau Life Pharmaceuticals (HRID) Contracts with U.S. Manufacturer to Produce New Female Supplement
7. Thomson Reuters Launches New Mobile Oncology Decision Support Solution for R&D Pharmaceutical Leaders
8. Amgen to Acquire Mustafa Nevzat, a Leading Privately Held Turkish Pharmaceutical Company
9. BioElectronics Survey Indicates a Five-Fold Superior Pain Relief Compared to OTC Pharmaceuticals
10. Icahn Issues Statement Regarding Amylin Pharmaceuticals
11. Almost 50 Percent of the Glaucoma Patient Population Remains Untreated, Signifying a Vast Market for Glaucoma Pharmaceuticals, Finds Frost & Sullivan
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2014)... BROOK, N.J. , Sept. 22, 2014 /PRNewswire/ ... antibody therapies to treat infectious disease, today announced ... volunteer safety studies of obiltoxaximab (ETI-204). Obiltoxaximab is ... inhalational anthrax and data from these studies support ... administered intravenously (IV) at the intended therapeutic dose. ...
(Date:9/22/2014)... , Sept. 22, 2014  AVT, Inc. (OTC Markets: ... systems and custom vending machines, announced today that they ... This new, smaller sized unit is designed for placement ... According to industry statistics, there are over ... Opticwash is the world,s first automated kiosk dedicated ...
(Date:9/22/2014)... , Sept. 22, 2014  Olympus, a global ... for medical and surgical procedures, among other core ... with Munich -based Brainlab to ... Navigation. This agreement applies to the US ... U.S. sales and all distribution outside the U.S. ...
Breaking Medicine Technology:Elusys Announces Results From Three Phase 3 Safety Studies Of Its Anthrax Anti-Toxin, Obiltoxaximab (ETI-204), In Adult Volunteers And Completion Of Its Phase 3 Clinical Development Program 2Elusys Announces Results From Three Phase 3 Safety Studies Of Its Anthrax Anti-Toxin, Obiltoxaximab (ETI-204), In Adult Volunteers And Completion Of Its Phase 3 Clinical Development Program 3Elusys Announces Results From Three Phase 3 Safety Studies Of Its Anthrax Anti-Toxin, Obiltoxaximab (ETI-204), In Adult Volunteers And Completion Of Its Phase 3 Clinical Development Program 4Elusys Announces Results From Three Phase 3 Safety Studies Of Its Anthrax Anti-Toxin, Obiltoxaximab (ETI-204), In Adult Volunteers And Completion Of Its Phase 3 Clinical Development Program 5Elusys Announces Results From Three Phase 3 Safety Studies Of Its Anthrax Anti-Toxin, Obiltoxaximab (ETI-204), In Adult Volunteers And Completion Of Its Phase 3 Clinical Development Program 6Opticwash Pro Enables Optical Retailers to Generate New Revenues and Customer Traffic through a Unique Eyeglass Cleaning System 2Olympus Partners with Brainlab as Exclusive Distributor for ENT Products in U.S. Market 2Olympus Partners with Brainlab as Exclusive Distributor for ENT Products in U.S. Market 3Olympus Partners with Brainlab as Exclusive Distributor for ENT Products in U.S. Market 4
(Date:9/22/2014)... A surprising new study pulls back the curtain on ... differences in payment and income between physicians who perform ... , Contrary to perception, the research indicates, the physician ... and other procedure-performing doctors. , The new findings counter ... pay per minute explains why doctors who perform procedures ...
(Date:9/22/2014)... Mozes HealthDay Reporter MONDAY, ... American parents are aware of online physician-rating sites, and more ... their children, according to a new national study. The ... -- further suggest that negative online ratings may dissuade parents ... recommended by a neighbor. Conversely, a positive online rating ...
(Date:9/22/2014)... South Asians living in Canada have a higher rate ... compared with while people, McMaster researchers have found. ... Canadian Medical Association Journal (CMAJ Open) and may ... the fastest-growing ethnic groups in the country is the ... Canada, comprising about three percent of the population. They ...
(Date:9/22/2014)... researchers have published a pilot study showing the ... people with multiple sclerosis (MS). Improvements were ... and pain. "Development and effectiveness of a ... Description and outcomes" was epublished ahead of print ... of MS Care (doi: 10.7224/1537-2073.2013-045). The authors ...
(Date:9/22/2014)... Two new prescription devices approved by the U.S. Food ... people with migraine headaches who don,t tolerate migraine medications ... -- the Cefaly -- is designed to prevent migraines, ... meant to be used when migraines first start, according ... looking for alternative migraine treatments. Because these devices aren,t ...
Breaking Medicine News(10 mins):Health News:Think the system for paying US doctors is rigged to favor surgeons? Study may surprise you 2Health News:Think the system for paying US doctors is rigged to favor surgeons? Study may surprise you 3Health News:Think the system for paying US doctors is rigged to favor surgeons? Study may surprise you 4Health News:Many Parents Use Online Ratings to Pick a Pediatrician, Study Finds 2Health News:Many Parents Use Online Ratings to Pick a Pediatrician, Study Finds 3Health News:Higher risk of heart disease for South Asians in Canada 2Health News:Noninvasive Devices May Help Migraines, FDA Says 2
... from several misconceptions that people had about aging. A popular ... the happiest days of people's lives occur when they're young ... ,While old age was equated with unhappiness for other people, ... their old age. In other words older people seem to ...
... it is evident that a man is very critical and is ... and is admitted// in a Shenzhen hospital. It is very evident ... SAR's Centre for Health Protection said that the victim lives in ... a Hong Konger residing in Shenzhen. He fell ill after he ...
... and figures seemingly indicate that the number of violent ... over the past year//. According to the figures that ... shows that the staff had reported 224 incidents of ... ,Unison an organization that represents the health workers, says ...
... Cancer researchers in UK exclaimed children now become fond of ... meat// and fish – after surveying about 200 pairs of ... strong in high-protein dishes such as beef, lamb, fish, bacon ... to taste vegetables and dessert more preferably. ,Mothers ...
... According to the study it was found that Implantable ... //. But they are very efficient in reducing the ... published in the American Heart Association rapid access journal ... were sicker and more prone to develop heart failure,’ ...
... seizures, or psychogenic seizures are often misdiagnosed as epileptic ... epilepsy is caused by the abnormal electrical activity in ... are similar to epileptic seizures, they can be difficult ... 13, 2006, issue of Neurology, the scientific journal of ...
Cached Medicine News:Health News:Attitudes About Aging Different from Reality 2Health News:Attitudes About Aging Different from Reality 3Health News:Violence Against NHS Staff On The Raise 2Health News:Defibrillators Can Only Put off Heart Failure but Cannot Prevent One 2Health News:Clues To Identify Psychological Seizures 2Health News:Clues To Identify Psychological Seizures 3
... and Fracture Table is a mobile, ... flexible, easy to use, articulated posturing ... orthopedic procedures. Radiolucent abductor bars, wedge-shaped ... exceptional imaging capability. OrthoVision folds into ...
... Field (PEMF) bone growth stimulation delivered by ... long bone and small bone nonunions. Physio-Stim ... brace, or clothing without lessening its effectiveness. ... compact, lightweight unit including success rates as ...
... implanted bone growth stimulator is a useful adjunct ... already planned or when patient compliance may be ... implanted, patients are assured of therapeutic treatment directly ... for up to 6 months. , ,The OsteoGen ...
Cannulated Interference Screws...
Medicine Products: